Business ❯Healthcare

Telehealth

Investments Market Analysis Earnings Reports Sales Growth Investor Relations Investment Telehealth Industry Dermatology Market Performance Health Technology

Novo Nordisk Ends Deal With Hims & Hers Over Compounded Wegovy Copycats

Novo Nordisk cited findings that Hims & Hers continued to sell unapproved Wegovy knock-offs after FDA-declared shortages lifted.

Stories older than 24h

Hims & Hers to Acquire Zava, Adding 1.3M Customers in Europe

Hims & Hers Reaffirms Growth Targets After Record Q1 Performance and Convertible Note Offering

Hims & Hers Reports Record Q1 Results While Stock Dips on Cautious Q2 Guidance

Novo Nordisk Partners with Telehealth Firms to Expand Wegovy Access

Hims & Hers Shuts Down Apostrophe to Streamline Dermatology Offerings

Hims & Hers Faces Stock Plunge After FDA Ends Semaglutide Shortage

Hims & Hers Expands into At-Home Lab Testing with Trybe Labs Acquisition